255
Participants
Start Date
April 30, 2008
Primary Completion Date
September 30, 2009
Study Completion Date
September 30, 2009
Atacicept
Atacicept will be administered subcutaneously at a dose of 25 milligram (mg) twice a week for initial 4 weeks as loading dose, followed by 25 mg once a week for subsequent 32 weeks.
Atacicept
Atacicept will be administered subcutaneously at a dose of 75 mg twice a week for initial 4 weeks as loading dose, followed by 75 mg once a week for subsequent 32 weeks.
Atacicept
Atacicept will be administered subcutaneously at a dose of 150 mg twice a week for initial 4 weeks as loading dose, followed by 150 mg once a week for subsequent 32 weeks.
Placebo matched to atacicept
Placebo matched to atacicept will be administered subcutaneously twice a week for initial 4 weeks, followed by once a week for subsequent 32 weeks.
Research Site, Phoenix
Research Site, Atlanta
Research Site, Northbrook
Research Site, East Lansing
Research Site, Jefferson
Research Site, Cleveland
Philadelphia
Research Site, Nashville
Research Site, Box Hill
Research Site, Fitzroy
Research Site, New Lambton
Research Site, Woodville
Research Site, Innsbruck
Research Site, Diepenbeek
Research Site, Sijsele
Research Site, Calgary
Research Site, Ottawa
Research Site, Ontario
Research Site, Brno
Research Site, Hradec Králové
Research Site, Olomouc
Research Site, Caen
Research Site, Saint-Herblain
Research Site, Bochum
Research Site, Düsseldorf
Research Site, Beirut
Research Site, Kaunas
Research Site, Breda
Research Site, Nieuwegein
Research Site, Rotterdam
Research Site, Dnipropetrovsk
Research Site, Moscow
Research Site, Novosibirsk
Research Site, Saint Petersburg
Research Site, Samara
Research Site, Vladimir
Research Site, Yaroslavl
Research Site, Yekaterinburg
Research Site, Barcelona
Research Site, Madrid
Research Site, Málaga
Research Site, Stockholm
Research Site, Basel
Research Site, Kharkiv
Research Site, Kyiv
Research Site, Odesa
Research Site, Uzhhorod
Research Site, London
Research Site, Sheffield
Research Site, Stoke-on-Trent
Lead Sponsor
EMD Serono
INDUSTRY